( 0 1 0 1 O
younger 1 8 1 8 O
than 9 13 9 13 O
21 14 16 14 16 B-upper_bound
years 17 22 17 22 I-upper_bound
of 23 25 23 25 O
age 26 29 26 29 B-age
) 29 30 29 30 O
; 30 31 30 31 O

Patient 0 7 32 39 O
must 8 12 40 44 O
also 13 17 45 49 O
have 18 22 50 54 O
at 23 25 55 57 O
least 26 31 58 63 O
one 32 35 64 67 B-lower_bound
cm 36 38 68 70 O
proximal 39 47 71 79 O
and 48 51 80 83 O
distal 52 58 84 90 O
landing 59 66 91 98 O
zones 67 72 99 104 O
in 73 75 105 107 O
the 76 79 108 111 O
ascending 80 89 112 121 O
aorta 90 95 122 127 O
between 96 103 128 135 O
28 104 106 136 138 B-lower_bound
- 106 107 138 139 O
44 107 109 139 141 B-upper_bound
mm 110 112 142 144 O
in 113 115 145 147 O
diameter 116 124 148 156 O
; 124 125 156 157 O

Patient 0 7 158 165 O
must 8 12 166 170 O
have 13 17 171 175 O
a 18 19 176 177 O
Type 20 24 178 182 B-treatment
A 25 26 183 184 I-treatment
thoracic 27 35 185 193 I-treatment
aortic 36 42 194 200 I-treatment
dissection 43 53 201 211 I-treatment
, 53 54 211 212 O
retrograde 55 65 213 223 B-treatment
Type 66 70 224 228 I-treatment
A 71 72 229 230 I-treatment
thoracic 73 81 231 239 I-treatment
aortic 82 88 240 246 I-treatment
dissection 89 99 247 257 I-treatment
, 99 100 257 258 O
intramural 101 111 259 269 B-treatment
hematoma 112 120 270 278 I-treatment
, 120 121 278 279 O
penetrating 122 133 280 291 B-chronic_disease
ulcer 134 139 292 297 I-chronic_disease
or 140 142 298 300 O
pseudoaneurysm 143 157 301 315 B-chronic_disease
of 158 160 316 318 O
the 161 164 319 322 O
ascending 165 174 323 332 O
thoracic 175 183 333 341 O
aorta 184 189 342 347 O
affecting 190 199 348 357 O
the 200 203 358 361 O
area 204 208 362 366 O
between 209 216 367 374 O
the 217 220 375 378 O
Sinus 221 226 379 384 O
of 227 229 385 387 O
Valsalva 230 238 388 396 O
and 239 242 397 400 O
the 243 246 401 404 O
innominate 247 257 405 415 O
artery 258 264 416 422 O
orifice 265 272 423 430 O
( 273 274 431 432 O
with 274 278 432 436 O
no 279 281 437 439 O
involvement 282 293 440 451 O
of 294 296 452 454 O
the 297 300 455 458 O
aortic 301 307 459 465 O
valve 308 313 466 471 O
) 313 314 471 472 O
and 315 318 473 476 O
be 319 321 477 479 O
considered 322 332 480 490 O
candidates 333 343 491 501 O
for 344 347 502 505 O
endovascular 348 360 506 518 O
repair 361 367 519 525 O
; 367 368 525 526 O

Patients 0 8 527 535 O
who 9 12 536 539 O
have 13 17 540 544 O
a 18 19 545 546 O
condition 20 29 547 556 O
that 30 34 557 561 O
threatens 35 44 562 571 O
to 45 47 572 574 O
infect 48 54 575 581 O
the 55 58 582 585 O
stent 59 64 586 591 B-treatment
graft 65 70 592 597 I-treatment
/ 70 71 597 598 O
aortic 71 77 598 604 B-treatment
valve 78 83 605 610 I-treatment
prosthesis 84 94 611 621 I-treatment
; 94 95 621 622 O

Patients 0 8 623 631 O
with 9 13 632 636 O
allergies 14 23 637 646 O
to 24 26 647 649 O
the 27 30 650 653 O
stent 31 36 654 659 B-allergy_name
graft 37 42 660 665 I-allergy_name
material 43 51 666 674 I-allergy_name
; 51 52 674 675 O

Patients 0 8 676 684 O
with 9 13 685 689 O
expected 14 22 690 698 B-clinical_variable
survival 23 31 699 707 I-clinical_variable
less 32 36 708 712 O
than 37 41 713 717 O
one 42 45 718 721 B-upper_bound
year 46 50 722 726 I-upper_bound

Pregnant 0 8 727 735 B-pregnancy
or 9 11 736 738 O
pediatric 12 21 739 748 O
patients 22 30 749 757 O

